205 related articles for article (PubMed ID: 37263544)
1. Targeting microbiome, drug metabolism, and drug delivery in oncology.
Sumiyoshi A; Fujii H; Okuma Y
Adv Drug Deliv Rev; 2023 Aug; 199():114902. PubMed ID: 37263544
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome: what the oncologist ought to know.
Lee KA; Luong MK; Shaw H; Nathan P; Bataille V; Spector TD
Br J Cancer; 2021 Oct; 125(9):1197-1209. PubMed ID: 34262150
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition.
Guardamagna M; Berciano-Guerrero MA; Villaescusa-González B; Perez-Ruiz E; Oliver J; Lavado-Valenzuela R; Rueda-Dominguez A; Barragán I; Queipo-Ortuño MI
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233289
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.
Zhou D; Li Y
Gut Microbes; 2023 Dec; 15(2):2276314. PubMed ID: 37943609
[TBL] [Abstract][Full Text] [Related]
5. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
McKenzie ND; Hong H; Ahmad S; Holloway RW
Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
Singh RP; Bashir H; Kumar R
Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
9. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma.
Pandya G; Kirtonia A; Singh A; Goel A; Mohan CD; Rangappa KS; Pandey AK; Kapoor S; Tandon S; Sethi G; Garg M
Semin Cancer Biol; 2022 Nov; 86(Pt 3):682-692. PubMed ID: 34051351
[TBL] [Abstract][Full Text] [Related]
12. Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review.
Pierrard J; Seront E
Curr Oncol; 2019 Dec; 26(6):395-403. PubMed ID: 31896938
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
[TBL] [Abstract][Full Text] [Related]
14. Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review).
Zhou Y; Han W; Feng Y; Wang Y; Sun T; Xu J
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38847233
[TBL] [Abstract][Full Text] [Related]
15. Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics.
Araujo DV; Watson GA; Oliva M; Heirali A; Coburn B; Spreafico A; Siu LL
Cancer Treat Rev; 2021 Jan; 92():102125. PubMed ID: 33227623
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
17. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications.
Lee KA; Shaw HM; Bataille V; Nathan P; Spector TD
Eur J Cancer; 2020 Oct; 138():149-155. PubMed ID: 32889369
[TBL] [Abstract][Full Text] [Related]
18. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
Wang M; Zhang L; Chang W; Zhang Y
Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-mediated immunomodulation in tumor.
Liu X; Chen Y; Zhang S; Dong L
J Exp Clin Cancer Res; 2021 Jul; 40(1):221. PubMed ID: 34217349
[TBL] [Abstract][Full Text] [Related]
20. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
